A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
about
Opioid antagonists for smoking cessationInterventions for preventing weight gain after smoking cessationNaloxone for hepatic encephalopathyInterventions for preventing weight gain after smoking cessationOpioid antagonists for smoking cessationSystematic review and meta-analysis of opioid antagonists for smoking cessationThe Yale Craving Scale: Development and psychometric properties.Racial differences in eligibility and enrollment in a smoking cessation clinical trialEndogenous opiates and behavior: 2006Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programsMultivariate longitudinal data analysis with mixed effects hidden Markov models.Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data.Acute HPA axis response to naltrexone differs in female vs. male smokers.The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature reviewTime to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence.A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.Translational Research on Nicotine Dependence.Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatmentIntolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders.Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trialExtended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessationThe opioid receptors as targets for drug abuse medicationSmoke and mirrors: magnified beliefs that cigarette smoking suppresses weight.Weight gain in smokers after quitting cigarettes: meta-analysis.Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersCurrent and emerging pharmacotherapies for treating tobacco dependence.Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomesValidation of a scale for the assessment of food cravings among smokersOverview of the pharmacogenomics of cigarette smoking.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
P2860
Q24202118-C5BC25BF-C631-48EF-B3D6-F5DF603C79FAQ24203883-F6B9421E-C7DC-47CD-A05D-F5C4941F1CEFQ24240885-326B06A8-D7B3-440C-B34E-0FBDB7C7942AQ24241751-02840014-3CCA-4131-9849-B2AE2DC3A19BQ24243850-8851DD53-D470-445E-8DBC-12FBE919813AQ26853570-0C95B000-6CE4-4A1E-A75D-00326D273371Q27312095-39724604-FD78-46F9-9083-88096AF0A441Q28386905-FBBC141F-CA95-4CF4-A15D-6AE9CE01DA03Q28752585-95BD0064-58C3-427A-AA79-689F002A9B1EQ30477221-DF171FDE-DCB2-4F32-905B-2FE76E7F4832Q30908696-07FBC935-589D-4F37-9ECF-57FE6DB4CAE9Q33379857-9C6E8516-9D75-41F7-9422-ABD5C1D0F9D2Q33746448-97DF936E-A314-4C15-9A33-EF894FE175F7Q33892368-D8A940E6-D06C-4D19-91A2-06635680F2B8Q34105568-BABEBFCC-0821-42DE-B20A-ACF57FF50007Q34111646-5C41C1A4-EE86-4BDC-A166-7EE0C16DAC9FQ34137677-B283D035-C636-48B6-9458-A0F325496F2EQ34161014-14E026B6-9911-420A-9236-B3ED84DB4C0CQ34167551-1D2BC577-91AF-4349-BB9A-602A6C82316FQ34513939-40DC3175-2F6D-4891-8FB5-A3157A7D1C11Q34982437-126A8A07-4792-406D-849B-ED04C8083D91Q34988416-F1A0F0A7-8D18-4EDF-ADCB-C899D2535514Q35007655-65B0F75B-4677-447F-B574-4CDF828D959AQ35195302-F63C9838-AB17-4C47-BEE2-E357D1086844Q35551196-70238159-921B-439F-8EA8-375EC437BB02Q35785818-51EAFF07-F116-43F3-8979-16BDBC22B99BQ35978068-8D258AC6-C7A6-441C-BC0B-660BECEAFCB7Q36012012-4F9DE265-B292-454B-A7FA-1DD0A8AA5BD8Q36087096-23B79695-DF3C-4DB4-A3CC-A615EFF77811Q36223647-D04B6DFA-BA2E-41DF-8BC0-308DA6E2C680Q36253208-6DC7963A-50B3-47ED-BC01-410FED1E2B96Q36263819-FC155125-8FA4-42B3-8664-CFF88957B1B2Q36267094-6F4153AC-FF22-4229-A45A-6F5DA9979769Q36294656-34839D9B-2DC8-4B38-93D3-6E8633F18EF4Q36580581-3EA85DD7-3A74-49F0-842B-DAA2792988C0Q36607738-996325D8-CD74-43F0-B4A6-46B99847840EQ36662470-0C716DAB-5ADD-4FA0-81E1-4842C1BEA436Q36708951-17C1D033-3195-40B8-8BB5-DD2408C3DFE6Q36774139-160D2274-4F76-491D-A487-BB6DB853A1C2Q36797159-E2D257FD-FBE1-4908-9924-4D602BE74BC3
P2860
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A controlled trial of naltrexo ...... therapy for smoking cessation.
@en
A controlled trial of naltrexo ...... therapy for smoking cessation.
@nl
type
label
A controlled trial of naltrexo ...... therapy for smoking cessation.
@en
A controlled trial of naltrexo ...... therapy for smoking cessation.
@nl
prefLabel
A controlled trial of naltrexo ...... therapy for smoking cessation.
@en
A controlled trial of naltrexo ...... therapy for smoking cessation.
@nl
P2093
P1476
A controlled trial of naltrexo ...... therapy for smoking cessation
@en
P2093
Amy Blakeslee
Boris Meandzija
Denise Romano-Dahlgard
Joel A Dubin
Judith L Cooney
Ned L Cooney
Peter Jatlow
Robert Makuch
Sherry A McKee
P304
P356
10.1001/ARCHINTE.166.6.667
P407
P577
2006-03-01T00:00:00Z